$HAE
HAEMONETICS CORP

2023 Q4 Form 10-Q Financial Statement

#000031314323000057 Filed on November 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2022 Q4
Revenue $336.3M $297.5M
YoY Change 13.03% 24.01%
Cost Of Revenue $158.4M $139.6M
YoY Change 13.47% 18.94%
Gross Profit $177.9M $157.9M
YoY Change 12.64% 28.86%
Gross Profit Margin 52.9% 53.08%
Selling, General & Admin $111.7M $92.15M
YoY Change 21.23% 21.6%
% of Gross Profit 62.81% 58.35%
Research & Development $13.27M $8.390M
YoY Change 58.1% -22.69%
% of Gross Profit 7.46% 5.31%
Depreciation & Amortization $14.20M $23.44M
YoY Change -39.41% -0.42%
% of Gross Profit 7.98% 14.84%
Operating Expenses $131.9M $108.8M
YoY Change 21.27% 10.94%
Operating Profit $45.98M $49.15M
YoY Change -6.45% 100.53%
Interest Expense -$1.949M -$5.673M
YoY Change -65.64% 23.65%
% of Operating Profit -4.24% -11.54%
Other Income/Expense, Net -$1.949M -$1.055M
YoY Change 84.74% -77.01%
Pretax Income $44.03M $41.06M
YoY Change 7.23% 106.1%
Income Tax $12.80M $7.862M
% Of Pretax Income 29.07% 19.15%
Net Earnings $31.24M $33.20M
YoY Change -5.89% 123.46%
Net Earnings / Revenue 9.29% 11.16%
Basic Earnings Per Share $0.62 $0.65
Diluted Earnings Per Share $0.61 $643.9K
COMMON SHARES
Basic Shares Outstanding 50.74M shares 50.51M shares
Diluted Shares Outstanding 51.45M shares 51.22M shares

Balance Sheet

Concept 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $194.0M $241.2M
YoY Change -19.58% 25.35%
Cash & Equivalents $194.0M $241.2M
Short-Term Investments
Other Short-Term Assets $55.37M $48.38M
YoY Change 14.45% 12.87%
Inventory $304.0M $254.7M
Prepaid Expenses
Receivables $211.6M $171.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $765.0M $715.8M
YoY Change 6.87% 2.37%
LONG-TERM ASSETS
Property, Plant & Equipment $318.7M $307.8M
YoY Change 3.52% 37.59%
Goodwill $555.0M $466.1M
YoY Change 19.07% -0.53%
Intangibles $429.3M $284.4M
YoY Change 50.95%
Long-Term Investments
YoY Change
Other Assets $127.4M $83.90M
YoY Change 51.9% 25.97%
Total Long-Term Assets $1.435B $1.149B
YoY Change 24.89% 4.27%
TOTAL ASSETS
Total Short-Term Assets $765.0M $715.8M
Total Long-Term Assets $1.435B $1.149B
Total Assets $2.200B $1.865B
YoY Change 17.98% 3.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.85M $61.48M
YoY Change -7.55% 36.73%
Accrued Expenses $58.76M $44.60M
YoY Change 31.77% 8.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $13.74M $58.19M
YoY Change -76.4% -29.66%
Total Short-Term Liabilities $261.8M $262.2M
YoY Change -0.16% -9.12%
LONG-TERM LIABILITIES
Long-Term Debt $856.8M $759.6M
YoY Change 12.81% 8.81%
Other Long-Term Liabilities $76.26M $78.40M
YoY Change -2.73% -14.65%
Total Long-Term Liabilities $933.1M $838.0M
YoY Change 11.36% 6.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $261.8M $262.2M
Total Long-Term Liabilities $933.1M $838.0M
Total Liabilities $1.195B $1.136B
YoY Change 5.17% 5.35%
SHAREHOLDERS EQUITY
Retained Earnings $340.1M $223.8M
YoY Change 51.98% 32.09%
Common Stock $627.6M $588.0M
YoY Change 6.74% 5.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $943.3M $729.0M
YoY Change
Total Liabilities & Shareholders Equity $2.200B $1.865B
YoY Change 17.98% 3.53%

Cashflow Statement

Concept 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income $31.24M $33.20M
YoY Change -5.89% 123.46%
Depreciation, Depletion And Amortization $14.20M $23.44M
YoY Change -39.41% -0.42%
Cash From Operating Activities -$530.0K $87.04M
YoY Change -100.61% 100.27%
INVESTING ACTIVITIES
Capital Expenditures $22.31M -$35.96M
YoY Change -162.05% 72.77%
Acquisitions
YoY Change
Other Investing Activities -$246.6M $4.889M
YoY Change -5144.43% 1574.32%
Cash From Investing Activities -$268.9M -$31.07M
YoY Change 765.63% 51.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$72.81M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 109.5M -25.69M
YoY Change -526.14% 674.84%
NET CHANGE
Cash From Operating Activities -530.0K 87.04M
Cash From Investing Activities -268.9M -31.07M
Cash From Financing Activities 109.5M -25.69M
Net Change In Cash -160.0M 30.29M
YoY Change -628.33% 54.32%
FREE CASH FLOW
Cash From Operating Activities -$530.0K $87.04M
Capital Expenditures $22.31M -$35.96M
Free Cash Flow -$22.84M $123.0M
YoY Change -118.57% 91.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50448519 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50448519 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
749424000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2459000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
127000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5299000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
19877000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6763000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
770423000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2192000 usd
CY2022Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
786000 shares
CY2022Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75000000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5735000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
33197000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7538000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
729009000 usd
us-gaap Net Income Loss
NetIncomeLoss
53074000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
45883000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1610000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
313000 usd
hae Benefit Provision For Losses On Inventory
BenefitProvisionForLossesOnInventory
-2559000 usd
hae Benefit Provision For Losses On Inventory
BenefitProvisionForLossesOnInventory
1529000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1836000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-2072000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2857000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17043000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30654000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-35990000 usd
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
906000 usd
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-2145000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
10291000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
7724000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18762000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8867000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
118210000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
129032000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34317000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81424000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2850000 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
850000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
921000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7537000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
7000000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
13395000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40396000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-89282000 usd
hae Proceeds From Issuance Of Long Term Debt Excluding Line Of Credit
ProceedsFromIssuanceOfLongTermDebtExcludingLineOfCredit
0 usd
hae Proceeds From Issuance Of Long Term Debt Excluding Line Of Credit
ProceedsFromIssuanceOfLongTermDebtExcludingLineOfCredit
280000000 usd
hae Decrease For Redemption Of Long Term Debt
DecreaseForRedemptionOfLongTermDebt
0 usd
hae Decrease For Redemption Of Long Term Debt
DecreaseForRedemptionOfLongTermDebt
280000000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
50000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5250000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6125000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1118000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
75000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
849000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
21593000 usd
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
2871000 usd
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
2459000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1319000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2319000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5842000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-19000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-23000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7770000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-49081000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3505000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8965000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
66539000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18296000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
284466000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259496000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
351005000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
241200000 usd
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
17523000 usd
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
66452000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
307766000 usd
CY2023Q3 us-gaap Investments
Investments
7000000 usd
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.78
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
31700000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
30200000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
20500000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
310885000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
13600000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
2150000 usd
us-gaap Restructuring Charges
RestructuringCharges
75000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
748000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
1477000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
86000 usd
us-gaap Restructuring Charges
RestructuringCharges
121000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
1500000 usd
CY2023Q3 hae Restructuring Charges Payable In Next Twelve Months
RestructuringChargesPayableInNextTwelveMonths
1100000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
86000 usd
CY2022Q4 us-gaap Restructuring Charges
RestructuringCharges
165000 usd
us-gaap Restructuring Charges
RestructuringCharges
75000 usd
us-gaap Restructuring Charges
RestructuringCharges
121000 usd
CY2023Q3 hae Restructuring Related Costs
RestructuringRelatedCosts
1947000 usd
CY2022Q4 hae Restructuring Related Costs
RestructuringRelatedCosts
3029000 usd
hae Restructuring Related Costs
RestructuringRelatedCosts
4151000 usd
hae Restructuring Related Costs
RestructuringRelatedCosts
6551000 usd
CY2023Q3 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
2033000 usd
CY2022Q4 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
3194000 usd
hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
6672000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18500000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.241
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.219
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13500000 usd
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.191
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.203
us-gaap Depreciation
Depreciation
26900000 usd
CY2022Q4 us-gaap Depreciation
Depreciation
12900000 usd
us-gaap Depreciation
Depreciation
24600000 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
4300000 usd
CY2022Q4 hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
46000 usd
hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
2899000 usd
hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
-712000 usd
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
-86000 usd
CY2022Q4 us-gaap Restructuring Costs
RestructuringCosts
-165000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
24908000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
33197000 usd
us-gaap Net Income Loss
NetIncomeLoss
65950000 usd
us-gaap Net Income Loss
NetIncomeLoss
53074000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50727000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50953000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50634000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51089000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
24908000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
33197000 usd
us-gaap Net Income Loss
NetIncomeLoss
65950000 usd
us-gaap Net Income Loss
NetIncomeLoss
53074000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50727000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50953000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50634000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51089000 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
669000 shares
CY2022Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
605000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
734000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
531000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51396000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51558000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51368000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51620000 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000 shares
CY2022Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000 usd
CY2022Q3 us-gaap Accelerated Share Repurchases Settlement Payment Or Receipt
AcceleratedShareRepurchasesSettlementPaymentOrReceipt
75000000 usd
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
225000000 usd
hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-7504000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
318183000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
297485000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
629515000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
132002000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
115016000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15258000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12572000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
138570000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
131791000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
285830000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
259379000 usd
CY2023Q3 us-gaap Inventory Adjustments
InventoryAdjustments
4300000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
949995000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
944215000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
642229000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
633330000 usd
hae Operating Lease Revenue As A Percentage Of Total Net Sales
OperatingLeaseRevenueAsAPercentageOfTotalNetSales
0.03
CY2023Q2 us-gaap Goodwill
Goodwill
466231000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-826000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
465405000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
659193000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
433092000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
226101000 usd
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
24403000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
672720000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
417422000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
255298000 usd
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
20473000 usd
CY2023Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
10400000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9400000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19200000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10600000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21300000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
18345000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
29705000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24023000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
22066000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
20294000 usd
CY2023Q3 hae Number Of Interest Rate Swaps Remaining
NumberOfInterestRateSwapsRemaining
2 segment
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5047000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2495000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4932000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2475000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-30000 usd
CY2022Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-59000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-181000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-204000 usd
CY2023Q3 hae Accounts Receivable Allowance For Credit Loss Recovery Writeoff
AccountsReceivableAllowanceForCreditLossRecoveryWriteoff
33000 usd
CY2022Q4 hae Accounts Receivable Allowance For Credit Loss Recovery Writeoff
AccountsReceivableAllowanceForCreditLossRecoveryWriteoff
59000 usd
hae Accounts Receivable Allowance For Credit Loss Recovery Writeoff
AccountsReceivableAllowanceForCreditLossRecoveryWriteoff
69000 usd
hae Accounts Receivable Allowance For Credit Loss Recovery Writeoff
AccountsReceivableAllowanceForCreditLossRecoveryWriteoff
184000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5044000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2495000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5044000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2495000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
558943000 usd
CY2023Q3 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
-3091000 usd
CY2022Q4 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
-51000 usd
hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
-478000 usd
hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
6194000 usd
CY2023Q3 hae Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
7222000 usd
CY2022Q4 hae Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
8221000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14695000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
16588000 usd
CY2023Q3 hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
1784000 usd
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
8700000 usd
us-gaap Inventory Recall Expense
InventoryRecallExpense
6500000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-30381000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-773000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
1551000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2324000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32705000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q3 hae Net Revenues By Business Unit Before Foreign Exchange Impact
NetRevenuesByBusinessUnitBeforeForeignExchangeImpact
314018000 usd
CY2022Q4 hae Net Revenues By Business Unit Before Foreign Exchange Impact
NetRevenuesByBusinessUnitBeforeForeignExchangeImpact
297102000 usd
hae Net Revenues By Business Unit Before Foreign Exchange Impact
NetRevenuesByBusinessUnitBeforeForeignExchangeImpact
619342000 usd
hae Net Revenues By Business Unit Before Foreign Exchange Impact
NetRevenuesByBusinessUnitBeforeForeignExchangeImpact
555901000 usd
CY2023Q3 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-880000 usd
CY2022Q4 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-5026000 usd
hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-636000 usd
hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
75000 usd
hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
121000 usd
CY2023Q3 hae Restructuring Related Costs
RestructuringRelatedCosts
1947000 usd
CY2022Q4 hae Restructuring Related Costs
RestructuringRelatedCosts
3029000 usd
hae Restructuring Related Costs
RestructuringRelatedCosts
4151000 usd
hae Restructuring Related Costs
RestructuringRelatedCosts
6551000 usd
CY2023Q3 hae Digital Transformation Costs
DigitalTransformationCosts
3592000 usd
CY2022Q4 hae Digital Transformation Costs
DigitalTransformationCosts
0 usd
hae Digital Transformation Costs
DigitalTransformationCosts
7297000 usd
hae Digital Transformation Costs
DigitalTransformationCosts
0 usd
CY2023Q3 hae Impairment Of Assets And Pcs2 Related Charges Credits
ImpairmentOfAssetsAndPCS2RelatedChargesCredits
-552000 usd
CY2022Q4 hae Impairment Of Assets And Pcs2 Related Charges Credits
ImpairmentOfAssetsAndPCS2RelatedChargesCredits
-83000 usd
hae Impairment Of Assets And Pcs2 Related Charges Credits
ImpairmentOfAssetsAndPCS2RelatedChargesCredits
411000 usd
hae Impairment Of Assets And Pcs2 Related Charges Credits
ImpairmentOfAssetsAndPCS2RelatedChargesCredits
-267000 usd
CY2023Q3 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
1988000 usd
CY2022Q4 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
2506000 usd
hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
3154000 usd
hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
5692000 usd
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
5449000 usd
CY2022Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
198000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
6507000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
394000 usd
CY2023Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
10419000 usd
CY2022Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
10419000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
382000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
382000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
35303000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
46732000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
88962000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
77499000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
318183000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
297485000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
629515000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
558943000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
318183000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
297485000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
629515000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
558943000 usd
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000313143-23-000057-index-headers.html Edgar Link pending
0000313143-23-000057-index.html Edgar Link pending
0000313143-23-000057.txt Edgar Link pending
0000313143-23-000057-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hae-20230930.htm Edgar Link pending
hae-20230930.xsd Edgar Link pending
hae-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
haefy24q2sepex311.htm Edgar Link pending
haefy24q2sepex312.htm Edgar Link pending
haefy24q2sepex321.htm Edgar Link pending
haefy24q2sepex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
hae-20230930_lab.xml Edgar Link unprocessable
hae-20230930_pre.xml Edgar Link unprocessable
hae-20230930_htm.xml Edgar Link completed
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hae-20230930_def.xml Edgar Link unprocessable